USPTO serial 86771138
2 PA PA-FORMULA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 16, 2017
- Examiner
- WATSON, JULIE A
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with 2 PA PA-FORMULA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
GOLDEN BIOTECHNOLOGY CORPORATION
New Taipei City, TW
GOLDEN BIOTECHNOLOGY CORPORATION
New Taipei City, TW
GOLDEN BIOTECHNOLOGY CORPORATION
New Taipei City, TW
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ziwen Zhu
ZIWEN ZHU Locke Lord LLPP.O. Box 1470Church Street StationNew York, NY 10008-1470Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Adjuvants for medical purposes; Antiallergic medicines; Anti-cancer preparations; Medicinal herbal extracts for medical purposes; Pharmaceutical and medicinal preparations and substances for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Pharmaceutical and medicinal preparations for the treatment of brain diseases or disorders and autoimmune diseases or disorders; Dietary and nutritional supplements for medical use; Dietary supplements for treating fatigue or liver support; Animal feed additive for use as a nutritional supplement for medical purposes; Dietary supplements for human consumption or for animals; Nutritional food additives for medical purposes for human consumption or animals in the nature of natural food extracts derived from soybean; Animal feed supplements; Dietary pet supplements in the form of pet treats; Fungi preparations for medical or veterinary use for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Pharmaceutical preparations and substances for veterinary purposes for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Chemical preparations for medicinal purposes for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Cardiovascular pharmaceuticals; Cardiovascular treatment preparations; Pharmaceuticals preparations for the treatment of kidney diseases | SECTION 8 - CANCELLED | Dec 6, 2016 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by GOLDEN BIOTECHNOLOGY CORPORATION
- Other trademarks owned by GOLDEN BIOTECHNOLOGY CORPORATION
- Other trademarks owned by GOLDEN BIOTECHNOLOGY CORPORATION
- Other trademarks in Class 005
- Similar marks named 2 PA PA-FORMULA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 1, 2023 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| May 16, 2022 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| May 16, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 11, 2017 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Apr 10, 2017 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Apr 8, 2017 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Apr 7, 2017 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 28, 2017 | IUAF | USE AMENDMENT FILED | — |
| Mar 28, 2017 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Dec 6, 2016 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 11, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 11, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 21, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 6, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 6, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 2, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 1, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 1, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 14, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 14, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 14, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 14, 2016 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jun 7, 2016 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| May 25, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 23, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 23, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 23, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 23, 2016 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 19, 2016 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 19, 2016 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 19, 2016 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 19, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 19, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 12, 2016 | ALIE | ASSIGNED TO LIE | — |
| May 2, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 22, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 15, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 15, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 15, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 15, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 2, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 1, 2015 | NWAP | NEW APPLICATION ENTERED | — |